Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial

被引：2

作者：

Ma, L. ^{[1
]}

Zhang, Y. ^{[2
]}

Fang, Y. ^{[3
]}

Hao, C. ^{[4
]}

Fan, Q. ^{[5
]}

Jiang, D. ^{[6
]}

Lu, L. ^{[7
]}

Su, F. ^{[8
]}

Yang, C. ^{[9
]}

Liu, Z. ^{[9
]}

Tian, J. ^{[9
]}

Sun, X. ^{[10
]}

Sun, S. ^{[11
]}

Cheng, Y. ^{[1
]}

机构：

[1] Jilin Canc Hosp, Internal Med, Changchun, Peoples R China

[2] Mianyang Cent Hosp, Oncol, Mianyang, Sichuan, Peoples R China

[3] Zhejiang Univ, Sir Run Run Run Shaw Hosp, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China

[4] Beijing Canc Hosp, Dept Hepatopancreatobiliary Surg 2, Beijing, Peoples R China

[5] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China

[6] Hebei Med Univ, Med Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China

[7] Zhejiang Prov Peoples Hosp, Med Oncol, Hangzhou, Peoples R China

[8] Bengbu Med Coll, Med Oncol, Affiliated Hosp 1, Bengbu, Peoples R China

[9] Shandong Simcere Biopharmaceut Co Ltd, Clin Sci, Shandong, Peoples R China

[10] Shandong Simcere Biopharmaceut Co Ltd, Clin Pharmacol, Nanjing, Peoples R China

[11] Shandong Simcere Biopharmaceut Co Ltd, Clin Stat, Yantai, Peoples R China

来源：

关键词：

D O I：

10.1016/j.annonc.2023.09.2105

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

959P

引用

页码：S599 / S600

页数：2